ACECLOFENAC LOADED SOLID LIPID NANOPARTICLES: OPTIMIZATION, IN VITRO AND EX-VIVO EVALUATION

PALAK GULATI; HITESH KUMAR DEWANGAN

doi:10.22159/ijap.2023v15i4.48047

Authors

PALAK GULATI University Institute of Pharma Sciences (UIPS), Chandigarh University NH-5, Chandigarh Ludhiana Highway, Mohali Punjab (India)
HITESH KUMAR DEWANGAN University Institute of Pharma Sciences (UIPS), Chandigarh University NH-5, Chandigarh Ludhiana Highway, Mohali Punjab (India) https://orcid.org/0000-0003-3440-1884

DOI:

https://doi.org/10.22159/ijap.2023v15i4.48047

Keywords:

Aceclofenac, Solid lipid nanoparticles, Rheumatoid arthritis, Lipid extrusion

Abstract

Objective: Rheumatoid arthritis is treated with aceclofenac as the first line of treatment. Aceclofenac is a BCS-II drug, when taken orally, causes first-pass metabolism and is partially water-insoluble causing some gastrointestinal (GI) issues. Objective of the work was preparation and evaluation of solid lipid nanoparticle for rheumatoid arthritis and increases the drug permeability and further possibility to decreasing the irritation.

Methods: Different formulations batches were prepared by soya lecithin, tween 20, bees wax and cetyl alcohol lipid using lipid extrusion method. Further, the selected batch proceeded for Particle size, zeta potential, entrapment efficiency, in vitro release, Fourier transformed infrared (FTIR), X-ray diffraction studies (XRD), and ex-vivo study in goat skin.

Results: As a result, selected batch have nanometric in size, 72.44% entrapment efficiency, and sustained drug released (71.33%) in 6 h. The Fourier transformed-infrared studies (FT-IR) and X-ray diffraction (XRD) study confirm the compatibility of the drug with excipients. Ex-vivo permeation study showed 74.85% in drug permeate in 6 h through goat skin.

Conclusion: Research demonstrates that particle size and entrapment effectiveness are significantly influenced by the level of lipid and lecithin present. Additionally, it is suitable for the treatment of arthritis.

Downloads

Download data is not yet available.

References

Shankar PR, Subish P, Mishra P. Quality control of traditional medicines: an approach to evaluation of botanicals. Indian J Pharmacol. 2003 Jul-Aug;35(4):274-7. PMID 23112535, PMCID PMC3558277.

Umeyor CE, Kenechukwu FC, Emmanuel MU, Uduma EC, Calistus Osonwa ND. Solid lipid microparticles (SLMS): an effective lipid based technology for controlled drug delivery. Am J PharmTech Res. 2012;2(6):789-801.

Gasco MR. Method for producing solid lipid microspheres having a narrow size distribution. United States Patent US; 1993. p. 188837.

Lakshmi L, Singh S, Vijayakumar MR, Dewangan HK. Lipid based aqueous core nanocapsules (ACNs) for encapsulating hydrophillic vinorelbine bitartrate: preparation, optimization, characterization and in vitro safety assessment for intravenous administration. Curr Drug Deliv. 2018 Sep;15(9):1284-93. doi: 10.2174/1567201815666180716112457, PMID 30009708.

Yadav RK, Shah K, Dewangan HK. Intranasal drug delivery of sumatriptan succinate-loaded polymeric solid lipid nanoparticles for brain targeting. Drug Dev Ind Pharm. 2022;48(1):21-8. doi: 10.1080/03639045.2022.2090575. PMID 35703403.

Doran MF, Pond GR, Crowson CS, O’Fallon WM, Gabriel SE. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum. 2002 Mar;46(3):625-31. doi: 10.1002/art.509, PMID 11920397.

McInnes IB, Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med. 2011 Dec 8;365(23):2205-19. doi: 10.1056/NEJMra1004965, PMID 22150039.

Semb AG, Ikdahl E, Wibetoe G, Crowson C, Rollefstad S. Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis. Nat Rev Rheumatol. 2020 Jul;16(7):361-79. doi: 10.1038/s41584-020-0428-y, PMID 32494054.

Pappas DA, Nyberg F, Kremer JM, Lampl K, Reed GW, Horne L. Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study. Clin Rheumatol. 2018 Sep;37(9):2331-40. doi: 10.1007/s10067-018-4113-3, PMID 29696436.

Saxena A, Raychaudhuri SK, Raychaudhuri SP. Rheumatoid arthritis: disease pathophysiology. In: Inflammation: advancing age and nutrition. Research and clinical interventions. Elsevier; 2013. p. 215-29. doi: 10.1016/B978-0-12-397803-5.00018-6.

Alunno A, Carubbi F, Giacomelli R, Gerli R. Cytokines in the pathogenesis of rheumatoid arthritis: new players and therapeutic targets. BMC Rheumatol. 2017 Nov 29;1(1):3. doi: 10.1186/S41927-017-0001-8, PMID 30886947, PMCID PMC6412019.

Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019 Nov 28;20(23):6008. doi: 10.3390/ijms20236008, PMID 31795299.

Ma X, Xu S. TNF inhibitor therapy for rheumatoid arthritis. Biomed Rep. 2013 Mar;1(2):177-84. doi: 10.3892/br.2012.42, PMID 24648915, PMCID PMC3915502.

Ruscitti P, Masedu F, Alvaro S, Airo P, Battafarano N, Cantarini L. Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): a multicentre, open-label, randomised controlled trial. PLOS Med. 2019;16(9):e1002901. doi: 10.1371/journal.pmed.1002901. PMID 31513665.

Goodman LS, Gilman A, Rall TW, Nies AS, Taylor P. Analgesic-antipyretics and anti-inflammatory agent: drug employed in the treatment of rheumatoid arthritis and gout. In: Brunton LL, Lazo JS, Parker KL, editors. Goodman and Gilman’s the pharmacological basis of therapeutics. 10th ed. New York: McGraw-Hill; 2001. p. 638-81.

Yadav D, Semwal BC, Dewangan HK. Grafting, characterization and enhancement of therapeutic activity of berberine loaded PEGylated PAMAM dendrimer for cancerous cell. J Biomater Sci Polym Ed. 2023;34(8):1053-66. doi: 10.1080/09205063.2022.2155782. PMID 36469754.

Lakshmi, Singh S, Shah K, Dewangan HK. Dual vinorelbine bitartrate and resveratrol loaded polymeric aqueous core nanocapsules for synergistic efficacy in breast cancer. J Microencapsul. 2022;39(4):299-313. doi: 10.1080/02652048.2022.2070679. PMID 35470755.

Ugazio E, Cavalli R, Gasco MR. Incorporation of cyclosporin a in solid lipid nanoparticles (SLN). Int J Pharm. 2002 Aug 2;241(2):341-4. doi: 10.1016/S0378-5173(02)00268-5, PMID 12100861.

Wissing SA, Müller RH. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm. 2003 Jan 23;254(1):65-8. doi: 10.1016/S0378-5173(02)00684-1, PMID 12615411.

Wissing SA, Muller RH. Cosmetic applications for solid lipid nanoparticles (SLN). Int J Pharm. 2003;254(1):65-8. doi: 10.1016/s0378-5173(02)00684-1. PMID 12615411.

Cacciatore I. Preface. Lett Drug Des Discov. 2023;20(1):1. doi: 10.2174/157018082001221122125217.

Sharma AN, Upadhyay PK, Dewangan HK. Development, evaluation, pharmacokinetic and biodistribution estimation of resveratrol-loaded solid lipid nanoparticles for prostate cancer targeting. J Microencapsul. 2022;39(6):563-74. doi: 10.1080/02652048.2022.2135785, PMID 36222429.

Dewangan HK, Sharma A, Mishra A, Singour P. Mucoadhesive microspheres of atorvastatin calcium: rational design, evaluation and enhancement of bioavailability. Indian J Pharm Educ Res. 2021;55(3s) Suppl 3:S733-41. doi: 10.5530/ijper.55.3s.180.

Rana S, Yousuf RI, Talegaonkar S, Ahmad FJ, Khar RK, Mahajan SC. Solid lipid nanoparticles: an efficient lipid-based technology for poorly water-soluble drugs. Int J Curr Pharm Res. 2012;4(1):1-8. PMID 23833550.

Wang KT, Wang WY, Wei TC. Photomask free, direct selective electroless deposition on glass by controlling surface hydrophilicity. ACS Omega. 2019;4(4):7706-10. doi: 10.1021/acsomega.9b00259. PMID 31459860.

Dewangan HK, Pandey T, Maurya L, Singh S. Rational design and evaluation of HBsAg polymeric nanoparticles as antigen delivery carriers. Int J Biol Macromol. 2018 Mar 15;111:804-12. doi: 10.1016/j.ijbiomac.2018.01.073. PMID 29343454.

Sharma V, Dewangan HK, Maurya L, Vats K, Verma H, Singh S. Rational design and in vivo estimation of Ivabradine hydrochloride loaded nanoparticles for management of stable angina. J Drug Deliv Sci Technol. 2019 Oct;54:101337-46. doi: 10.1016/j.jddst.2019.101337. PMID 31831995.

Sarwar HS, Sarwar S, Anwar F. Assessment of stability, in vitro release and bioactivity of simvastatin loaded PLGA nanoparticles. Int J Appl Pharm. 2018 Jul-Aug;10(4):63-72. PMID 30956963, PMCID PMC6441582.

Srinivasan M, Rajabi Siahboomi AR. Preparation and characterization of rosmarinic acid-loaded solid lipid nanoparticles. Asian J Pharm Clin Res. 2019 Aug;12(8):372-9. doi: 10.22159/ajpcr.2019. v12i8.33954.

Bhatt P, Madan P, Lin S. Development of solid lipid nanoparticle formulations for oral delivery of poorly water-soluble drugs: challenges and opportunities. Drug Deliv Transl Res. 2015 Aug;5(4):319-37. doi: 10.1007/s13346-015-0245-5, PMID 26337878.

Wissing SA, Kayser O, Muller RH. Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 2004;56(9):1257-72. doi: 10.1016/j.addr.2003.12.002. PMID 15109768.

Deepika D, Dewangan HK, Maurya L, Singh S. Intranasal drug delivery of frovatriptan succinate-loaded polymeric nanoparticles for brain targeting. J Pharm Sci. 2019 Feb;108(2):851-9. doi: 10.1016/j.xphs.2018.07.013. PMID 30053555.

Dewangan HK, Singh S, Maurya L, Srivastava A. Hepatitis b antigen loaded biodegradable polymeric nanoparticles: formulation optimization and in vivo immunization in BALB/c mice. Curr Drug Deliv. 2018;15(8):1204-15. doi: 10.2174/1567201815666180604110457, PMID 29866006.

Patel P, Raval M, Airao V, Bhatt V, Shah P. Silibinin loaded inhalable solid lipid nanoparticles for lung targeting. J Microencapsul. 2022;39(1):1-24. doi: 10.1080/02652048.2021.2002448. PMID 34825627.

Gaba B, Fazil M, Khan S, Ali A. Development and optimization of solid lipid nanoparticles of mifepristone for effective anti-proliferative activity against MCF-7 breast cancer cell line. Int J Pharm Sci Res. 2018 Apr;9(4):1529-40. PMID 29805438, PMCID PMC5968749.

Shirsat SR, Jadhav SS, Yadav VB. Development and evaluation of aceclofenac-loaded solid lipid nanoparticle formulation for topical delivery. Int J Appl Pharm. 2015;7(1):7-12:1529-40. PMID: 29805438. PMID 29491546, PMCID PMC5817412.

Ghode P, Musmade PB, Khan A. Design and evaluation of aceclofenac-loaded solid lipid nanoparticles for controlled release. Int J Appl Pharm. 2019 Jan-Feb;11(1):196-202. doi: 10.22159/ijap.2019v11i1.29460.

Dewangan HK, Singh S, Mishra R, Dubey RK. A review on application of nanoadjuvant as delivery system. Int J App Pharm. 2020;12(4):24-33. doi: 10.22159/ijap.2020v12i4.36856.